Synergistic Effects of Dietary Protein and Vitamin E Intake on Reducing Metabolic‐Associated Fatty Liver Disease Risk: Insights From <scp>NHANES</scp> [2017–2023] and Mendelian Randomization Study

Weijie Wu, Jiansheng Chen, Zhiwen Shen, Xiaona Lin, Chaoying Fang, Yunzhe Yu, Linda M. Liao, Ai‐Ming Zeng, Wenqing DingFood 2025 · DOI

TL;DR

This study reveals that a combined high intake of dietary protein and vitamin E significantly reduces the risk of metabolic-associated fatty liver disease (MAFLD), with a synergistic effect that's more potent than either nutrient alone. The research, using NHANES data and Mendelian randomization, also highlights sex-specific differences in these protective effects, suggesting tailored nutritional strategies.

What Problem Does This Paper Address?

Metabolic-associated fatty liver disease (MAFLD) is a growing global health concern, affecting over 32% of the population and linked to serious health complications. While dietary interventions are key to managing MAFLD, the specific impact of combined nutrients, particularly protein and vitamin E, has remained unclear. Existing research often focuses on individual nutrients, leaving a gap in understanding how these macronutrients and micronutrients might work together synergistically to prevent or mitigate MAFLD. This paper aims to fill that gap by investigating the combined effects of protein and vitamin E intake on MAFLD risk.

Methods

The study employed a two-pronged approach:

  1. Observational Analysis (NHANES Data):
    • Participant Selection: 14,489 participants from the 2017-2023 NHANES dataset were analyzed. MAFLD was diagnosed based on liver fat accumulation and the presence of metabolic syndrome components.
  2. Nutrient Intake Assessment: Protein and vitamin E intake were assessed using two 24-hour dietary recalls, with daily intake normalized to body weight.
  3. Statistical Modeling: Multivariable logistic regression was used to assess the association between nutrient intake and MAFLD risk. Restricted cubic spline (RCS) modeling explored dose-response relationships. Participants were categorized into four groups based on low/high protein and vitamin E intake to evaluate combined effects. Internal validation (70% training, 30% testing) was performed to ensure model robustness, including ROC curves, calibration curves, and decision curve analysis. Gender-specific analyses were conducted to explore effect heterogeneity.
  4. Genetic Analysis (Mendelian Randomization - MR):
    • Instrumental Variables (IVs): Single nucleotide polymorphisms (SNPs) strongly associated with a-tocopherol (the active form of vitamin E) and protein intake were identified from large genome-wide association studies (GWAS) datasets (UK Biobank, MAFLD GWAS).
  5. MR Analysis: Two-sample MR was performed using various methods (IVW, Weighted Median, MR-Egger) to assess the causal relationship between a-tocopherol and protein intake with MAFLD risk. Sensitivity analyses (MR-PRESSO, leave-one-out) were used to detect and address pleiotropy.
  6. Summary-data-based Mendelian Randomization (SMR): This method was used to investigate potential causal links between genetic variants associated with protein intake, gene expression, and MAFLD risk.

Datasets

  • National Health and Nutrition Examination Survey (NHANES) [2017-2023]: This is the primary dataset for the observational analysis, providing comprehensive nutritional, health, and demographic data for a nationally representative sample of the US civilian population.
  • UK Biobank: Used to derive genetic instruments (SNPs) for protein and a-tocopherol levels.
  • MAFLD GWAS Dataset: Used to derive genetic instruments for MAFLD cases and controls.

Key Insights and Ideas

  • Synergistic Effect: The most striking finding is the synergistic protective effect of combined high protein and vitamin E intake. This suggests that these nutrients don't just act independently but enhance each other's benefits against MAFLD.
  • Beyond Individual Nutrients: The study moves beyond looking at protein or vitamin E in isolation, providing evidence for a "nutrient combination" strategy, which is crucial given the complexity of MAFLD.
  • Sex-Specific Differences: The protective effects are not uniform across genders. While both sexes benefit, the study hints at nuanced responses, suggesting that women might be more responsive to certain combinations, while men might require sufficient vitamin E due to higher baseline risks.
  • Genetic Validation for Vitamin E: Mendelian randomization provides strong evidence that higher a-tocopherol levels causally reduce MAFLD risk, lending genetic support to the observational findings.
  • Protein's Indirect Role: While direct causality between protein intake and MAFLD wasn't confirmed via MR, the SMR analysis suggests protein might influence MAFLD indirectly through genes like CA11, highlighting a more complex genetic pathway.

Key Results

  • Reduced MAFLD Risk: Participants with high protein (>0.82 g/kg/d) and high vitamin E (>0.140 mg/kg/d) intake had a 72% lower risk of MAFLD (OR=0.280) compared to those with low intake of both.
  • Dose-Response: Higher quartiles of both protein and vitamin E intake were independently associated with a significantly lower prevalence of MAFLD.
  • Vitamin E Causality: MR analysis showed that higher a-tocopherol levels were causally associated with a lower risk of MAFLD (IVW OR=0.871, p=0.015).
  • Protein's Genetic Link: While direct protein intake causality wasn't significant in MR, genetic variants associated with protein intake were linked to MAFLD risk through the regulation of carbonic anhydrase 11 (CA11) expression.
  • Model Performance: The predictive model developed showed good discrimination (AUC ~0.73) and calibration, indicating robustness.

Limitations and Future Work

  • Dietary Recall Limitations: The study relied on 24-hour dietary recalls, which can be subject to recall bias and may not perfectly capture long-term dietary patterns.
  • Unmeasured Confounders: Despite adjusting for many factors, unmeasured confounders like the gut microbiome or specific protein sources could still influence the results.
  • Limited Genetic Instruments: The MR analysis for protein intake was limited by the number of available SNPs, potentially affecting the power to detect causal relationships.
  • Future Directions:
    • Prospective Trials: The authors strongly recommend prospective randomized controlled trials to confirm the efficacy of combined vitamin E and protein interventions.
  • Sex-Specific Strategies: Further research is needed to clarify sex-specific nutritional strategies, potentially incorporating hormonal interactions.
  • Protein Source Differentiation: Future studies should classify protein sources (animal vs. plant) to better understand their differential effects.
  • Expanded GWAS: Larger GWAS datasets are needed to refine causal relationships for protein intake.
  • External Validation: Validation in independent cohorts is crucial to confirm the generalizability of the findings.

Summary updated

Abstract

Nutritional intervention plays a pivotal role in managing metabolic-associated fatty liver disease (MAFLD), but the combined effect of protein and vitamin E on MAFLD remains indistinct. This study sought to evaluate the synergistic effects of these nutrients on MAFLD. This study enrolled 14,489 participants from the NHANES database. MAFLD was defined by liver fat accumulation and metabolic syndrome components. Multivariable logistic regression, restricted cubic spline modeling, and internal validation were applied to assess the dose-response and joint effects of protein and vitamin E, with gender stratification to explore effect heterogeneity. A Mendelian randomization (MR) approach was utilized to probe the causality between α-tocopherol and protein intake with MAFLD. Intake levels of protein and vitamin E were significantly reduced in individuals with MAFLD compared to the non-MAFLD group (All <i>p</i> < 0.001). Multivariable logistic regression analysis indicated that combined intake of high protein (> 0.82 g/kg/d) and vitamin E (> 0.140 mg/kg/d) significantly reduced the risk of MAFLD by 72% (OR = 0.280, 95% CI: 0.244-0.320, <i>p</i> < 0.001), outperforming the high intake of either nutrient alone; internal validation further confirmed the robustness of the model. Sex-stratified analysis indicated that elevated intake of protein and vitamin E was associated with a significantly decreased risk of MAFLD in both males and females. MR analysis confirmed that high α-tocopherol was causally related to a lower risk of MAFLD (IVW OR = 0.871, 95% CI: 0.780-0.973, <i>p</i> = 0.015). Although the causality between protein intake and MAFLD was not statistically significant, further analysis indicated that protein intake-associated genetic variants may influence MAFLD through the regulation of carbonic anhydrase 11 expression. This study revealed that combined intake of protein and vitamin E exerts a synergistic protective effect against MAFLD, with gender-specific effects. It provides translational medical evidence for developing nutrient-combination-based therapeutic strategies for MAFLD.
BibTeX
@inproceedings{wu2025synergistic,
  author = {Weijie Wu and Jiansheng Chen and Zhiwen Shen and Xiaona Lin and Chaoying Fang and Yunzhe Yu and Linda M. Liao and Ai‐Ming Zeng and Wenqing Ding},
  title = {{Synergistic Effects of Dietary Protein and Vitamin E Intake on Reducing Metabolic‐Associated Fatty Liver Disease Risk: Insights From <scp>NHANES</scp> [2017–2023] and Mendelian Randomization Study}},
  booktitle = {Food},
  year = {2025},
  doi = {10.1002/fsn3.71026},
}
Figure